Now, Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage ...

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...

Learn more about how a research team has successfully used CRISPR gene editing in the fight against cancer.

Transgenic worm in which the splicing factor UNC-75, marked with the fluorophore mScarlet, reveals its expression throughout the nervous system. The worm was generated using CRISPR-Cas9 gene editing ...

A new CRISPR-based technology, called RIDE, is a leap forward for this trail-blazing technology. With the precision of a ...

CRISPR is a technology that allows scientists ... The Facebook post was shared more than 300 times in three days. The image also circulated on X, Instagram and elsewhere on Facebook.

Using gene editing with CRISPR-Cas9, the team has been able to study these proteins without altering ... Dec. 13, 2024 — Microorganisms produce a wide variety of natural products that can be ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

AWS’s framework will speed up the analysis of ElevateBio’s large protein datasets, hinting at promising drug candidates.

Getty Images. In 2020, American biochemist Jennifer Doudna and French microbiologist Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for their discovery of the CRISPR gene-editing ...